Long-chain Fatty Acid Oxidation Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-07-28
Clinical Trial Update: Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects [Phase 3]
A Phase 3 trial of Triheptanoin for long-chain fatty acid oxidation disorders has been withdrawn.